Cargando…
Development and In Vitro and In Vivo Evaluation of an Antineoplastic Copper(II) Compound (Casiopeina III-ia) Loaded in Nonionic Vesicles Using Quality by Design
In recent decades, the interest in metallodrugs as therapeutic agents has increased. Casiopeinas are copper-based compounds that have been evaluated in several tumor cell lines. Currently, casiopeina III-ia (CasIII-ia) is being evaluated in phase I clinical trials. The aim of the present work is to...
Autores principales: | Aguilar-Jiménez, Zenayda, González-Ballesteros, Mauricio, Dávila-Manzanilla, Silvia G., Espinoza-Guillén, Adrián, Ruiz-Azuara, Lena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655312/ https://www.ncbi.nlm.nih.gov/pubmed/36361549 http://dx.doi.org/10.3390/ijms232112756 |
Ejemplares similares
-
Investigation on the self-association of an inorganic coordination compound with biological activity (Casiopeína III-ia) in aqueous solution
por: Marín-Medina, Alejandro, et al.
Publicado: (2016) -
Intermediate Detection in the Casiopeina–Cysteine Interaction Ending in the Disulfide Bond Formation and Copper Reduction
por: Ramírez-Palma, Lillian G., et al.
Publicado: (2021) -
Ex Vivo Cardiotoxicity of Antineoplastic Casiopeinas Is Mediated through Energetic Dysfunction and Triggered Mitochondrial-Dependent Apoptosis
por: Silva-Platas, Christian, et al.
Publicado: (2018) -
Whole Genome Gene Expression Analysis Reveals Casiopeína-Induced Apoptosis Pathways
por: Valencia-Cruz, Alejandra Idan, et al.
Publicado: (2013) -
(1)H -NMR Metabolomics Study of the Effect of Cisplatin and Casiopeina IIgly on MDA-MB-231 Breast Tumor Cells
por: Resendiz-Acevedo, Karen, et al.
Publicado: (2021)